Advocates say there aren’t enough of them in Texas long-term care facilitiesUser-Generated Content Platform Market: $4.4B in 2022 to $44.75B by 2031 12-05-2024 09:45 PM CET | IT, New Media & Software Press release from: SkyQuest Technology. User Generated Content Platform Market Scope: Key Insights : User Generated Content Platform Market size was valued at USD 4.4 billion in 2022 and is poised to grow from USD 5.69 billion in 2023 to USD 44.75 billion by 2031, growing at a CAGR of 29.4% during the forecast period (2024-2031). Discover Your Competitive Edge with a Free Sample Report : https://www.skyquestt.com/sample-request/user-generated-content-platform-market Access the full 2024 Market report for a comprehensive understanding @ https://www.skyquestt.com/report/user-generated-content-platform-market In-Depth Exploration of the global User Generated Content Platform Market: This report offers a thorough exploration of the global User Generated Content Platform market, presenting a wealth of data that has been meticulously researched and analyzed. It identifies and examines the crucial market drivers, including pricing strategies, competitive landscapes, market dynamics, and regional growth trends. By outlining how these factors impact overall market performance, the report provides invaluable insights for stakeholders looking to navigate this complex terrain. Additionally, it features comprehensive profiles of leading market players, detailing essential metrics such as production capabilities, revenue streams, market value, volume, market share, and anticipated growth rates. This report serves as a vital resource for businesses seeking to make informed decisions in a rapidly evolving market. Trends and Insights Leading to Growth Opportunities The best insights for investment decisions stem from understanding major market trends, which simplify the decision-making process for potential investors. The research strives to discover multiple growth opportunities that readers can evaluate and potentially capitalize on, armed with all relevant data. Through a comprehensive assessment of important growth factors, including pricing, production, profit margins, and the value chain, market growth can be more accurately forecast for the upcoming years. Top Firms Evaluated in the Global User Generated Content Platform Market Research Report: CrowdRiff Grin Technologies Inc. Taggbox Upfluence Wyng Yotpo VN Secure by Viral Nation LTK Cookpad Key Aspects of the Report: Market Summary: The report includes an overview of products/services, emphasizing the global User Generated Content Platform market's overall size. It provides a summary of the segmentation analysis, focusing on product/service types, applications, and regional categories, along with revenue and sales forecasts. Competitive Analysis: This segment presents information on market trends and conditions, analyzing various manufacturers. It includes data regarding average prices, as well as revenue and sales distributions for individual players in the market. Business Profiles: This chapter provides a thorough examination of the financial and strategic data for leading players in the global User Generated Content Platform market, covering product/service descriptions, portfolios, geographic reach, and revenue divisions. Sales Analysis by Region: This section provides data on market performance, detailing revenue, sales, and market share across regions. It also includes projections for sales growth rates and pricing strategies for each regional market, such as: North America: United States, Canada, and Mexico Europe: Germany, France, UK, Russia, and Italy Asia-Pacific: China, Japan, Korea, India, and Southeast Asia South America: Brazil, Argentina, Colombia, etc. Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, and South Africa This in-depth research study has the capability to tackle a range of significant questions that are pivotal for understanding the market dynamics, and it specifically aims to answer the following key inquiries: How big could the global User Generated Content Platform market become by the end of the forecast period? Let's explore the exciting possibilities! Will the current market leader in the global User Generated Content Platform segment continue to hold its ground, or is change on the horizon? Which regions are poised to experience the most explosive growth in the User Generated Content Platform market? Discover where the future opportunities lie! Is there a particular player that stands out as the dominant force in the global User Generated Content Platform market? Let's find out who's leading the charge! What are the key factors driving growth and the challenges holding back the global User Generated Content Platform market? Join us as we uncover the forces at play! To establish the important thing traits, Ask Our Experts @ https://www.skyquestt.com/speak-with-analyst/user-generated-content-platform-market Table of Contents Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.5 Market Size Analysis from 2023 to 2030 11.6 COVID-19 Outbreak: Medical Computer Cart Industry Impact Chapter 2 Competition by Types, Applications, and Top Regions and Countries 2.1 Market (Volume and Value) by Type 2.3 Market (Volume and Value) by Regions Chapter 3 Production Market Analysis 3.1 Worldwide Production Market Analysis 3.2 Regional Production Market Analysis Chapter 4 Medical Computer Cart Sales, Consumption, Export, Import by Regions (2023-2023) Chapter 5 North America Market Analysis Chapter 6 East Asia Market Analysis Chapter 7 Europe Market Analysis Chapter 8 South Asia Market Analysis Chapter 9 Southeast Asia Market Analysis Chapter 10 Middle East Market Analysis Chapter 11 Africa Market Analysis Chapter 12 Oceania Market Analysis Chapter 13 Latin America Market Analysis Chapter 14 Company Profiles and Key Figures in Medical Computer Cart Business Chapter 15 Market Forecast (2023-2030) Chapter 16 Conclusions Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 351-333-4748 Email: sales@skyquestt.com About Us: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. This release was published on openPR.
Cowboys linebacker DeMarvion Overshown could miss 2025 season after latest knee injury, coach says
NonePresident-elect Trump's the next director of the FBI would be a serious mistake that could haunt America for decades, writes historian and journalist Garrett M. Graff in a op-ed. Patel's only qualification for the post seems to be that he is fiercely loyal to Trump and willing to do his bidding, writes Graff. He argues that the agency has a long history of independence in its post-Hoover years, in part because directors serve 10-year terms that overlap presidencies. (Trump wants to break with that tradition and oust current director Christopher Wray three years early.) "What this independence illustrates is that the FBI is not, as many MAGA loyalists believe, some liberal bastion of wokeness," writes Graff, who points out that no Democrat has ever served as permanent director of the agency. "Trump has been clear in what he is trying to do with a nominee like Mr. Patel: He wants to bend and break the bureau and weaponize it against those he sees as his political enemies and domestic critics," writes Graff. Putting someone like Patel in charge even for a few years "could cause grave, lasting harm to the institution," he adds. That harm would come from the promotion of like-minded people into top positions, with those choices shaping "the bureau for decades." (Read the .)Biden says he was ‘stupid’ not to put his name on pandemic relief checks like Trump did
Gunman wounds two children at US school, kills selfServe Robotics Announces Appointment of Lily Sarafan to its Board of Directors
Moving from one school to another is nothing new for quarterback Brooks Bentley. He played for three football programs during his high school career, and the University of New Hampshire will be the second team he’s played for in college. Bentley, who spent the last two seasons at Division II Wingate University in Wingate, N.C., entered the transfer portal after the 2024 season and committed to UNH earlier this month. He spent two seasons at River Bluff High School in Lexington, South Carolina; transferred to Gaither High School in Tampa, Florida, for his junior year; and played 7A football at Venice (Florida) High School as a senior. “My dad was a college football coach so I’ve moved around,” Bentley said. “It was definitely tough, but it was a fun experience to move around and meet new people – see new programs in new areas. It was a fun experience to have, I really enjoyed it.” Bentley said he didn’t know much about the UNH program until he spoke with UNH quarterbacks coach Drew Belcher after Belcher initiated contact while Bentley was in the transfer portal. “Really enjoyed my visit,” Bentley said. “Felt like a great place for me to be, so I went home and talked about it with my family. It seemed like the right place for me, the right fit. Really loved the coaching staff. First thing we did was go to the coaches office and there were players there hanging around and it just showed the culture that’s there and the connection. “Obviously the success they’ve had at the quarterback position over the last couple years was a big selling point, and just how successful the program’s been. I wanted to go somewhere where I had a chance to win and be in a great program. For me seeing the success the program’s had as a team and at the quarterback position I felt like they could develop me and it just seemed like that was the best place for me.” Bentley is 6-foot-3 and 210 pounds. He described himself as a pocket passer who can run when needed. He took over as Wingate’s starting quarterback four games into his freshman season. The Bulldogs were 16-3 in games he started. Bentley was selected as the South Atlantic Conference Freshman of the Year in 2023, when he completed 126 of 191 passes for 1,834 yards and 13 touchdowns with four interceptions and ran for 141 yards and four TDs. He completed 139 of 246 passes for 1,852 yards and 14 touchdowns with six interceptions last season, when Wingate won the conference championship. “I would say more of a passer,” Bentley said. “Someone who stays in the pocket and tries to deliver to the athletes and let them make plays. I can definitely run around and make plays with my legs when I need to. I think that’s part of my game I can utilize and make defenses keep honest.” Bentley has two seasons of eligibility left, not including his redshirt season. Seth Morgan, UNH’s starting quarterback last season, no longer has eligibility remaining, so Bentley will join a quarterback room that includes sophomore Barry Kleinpeter, redshirt freshmen Matt Vezza and Matt Festa, and true freshman Tommy McLeish. Bentley said he plans to enroll for the spring semester. “I need some cold clothes,” he said.
Hold onto your bookmarks. The list of our 10 most-loved books published since 2000 spans the literary, experimental and translated as well as true crime, science fiction and memoir genres. Some will make you cry, others will make you laugh – the best will have you doing both. Choosing only 10 books from 25 years means there are notable absences, but the list offers a sketch of the books that have shaped us and our world since the start of the millennium. Our writers, critics and editors were asked to consider their personal favourites – the books that will always have a place on their shelves – as well as quality, influence and legacy. How many have you read? W G Sebald was the German master who invented contemporary “faction”, and is the last of his longer works and the one which most resembles a novel. The main character shares a name with the famous Napoleonic battle and he speaks in moody and melancholic arias of desolation over a period that stretches from the 1960s to the 1990s. Austerlitz hates the aggressive brutality of the architecture of Antwerp and exhibits a depth of melancholy that is the basic idiom of his self-delineation and Sebald’s characterisation. This is a mutation of fiction which has the self-validating intensity of great poetry. is a labyrinth of a book in which dream worlds and real worlds shatter and collide. It’s manifestly a masterpiece, perhaps the very greatest of those works which insinuate and actualise the way in which the mind transfigured the world it depicts. There was once a time when comic books were considered child’s play – throwaway fluff for the emotionally and socially stunted. At the turn of the millennium, the great graphic novels boom happened and suddenly everyone realised they’d unfairly dismissed the literary potential of books with pictures. Marjane Satrapi’s , Chris Ware’s and Alison Bechdel’s were among the era’s most acclaimed titles, alongside my moody favourite Craig Thompson’s – a romantic and melancholic coming-of-age story charting the author’s world-opening first love and spirited questioning of his religious upbringing. It all plays like a Softies song – deeply evocative and earnest and reflective, Thompson’s snow-dotted panels are filled with the sort of quiet space that stops you in your tracks repeatedly, something run-on sentences could never do. As my copy’s coffee-stained jacket, quoting Pulitzer winning cartoonist Jules Feiffer, somewhat defensively suggests: “I’d call that literature.” These days, we’re inundated with true crime content — podcasts, documentaries, books and TV shows — but none come close to the moral inquiry, literary craftsmanship and utter elegance of Helen Garner’s . The non-fiction work follows the murder trial of Anu Singh, a law student at ANU in Canberra, and her best friend, who were accused of murdering Singh’s boyfriend, engineering student Joe Cinque, in 1997 with a lethal dose of heroin and Rohypnol. Singh had allegedly organised two dinner parties before the murder, hinting to her friends about her plans, but none intervened. Garner’s work avoids easy conclusions and oversimplification, combining sharp analysis with deep empathy to transform a personal tragedy into a universal exploration of justice, grief and human frailty. If only this self-reflective, philosophical book was the standard for all works about true criminal cases. Kathy, Ruth and Tommy are special children growing up in a curiously old-fashioned boarding school with kind teachers. Already the place and time is lit with a nostalgic glow. Kathy, now an adult, looks back without rancour on those formative years and the close ties with her two friends. Gradually, the world surrounding the school is revealed. You may see the twist coming, but it doesn’t matter, because is unexpected in different ways. ’s delicate handling transcends his science fiction premise and in simple understated language graced with dignified euphemisms tells us a complex and profoundly moving love story. The reader may be shocked and angry, but the characters never are, and we respect that. Kathy’s memories add up to a meditation on human connection, what we can keep and what we have to lose. The last scene, in which Kathy contemplates rubbish flapping on a barbed wire fence, has never left me. “Time’s a goon, you gonna let that goon push you around?” says Scotty Hausman. He’s a failed guitarist who leaves a dead fish in the office of a friend whose success he resents in , Jennifer Egan’s ode to Proust by way of that I devoured when it came out. Egan’s kaleidoscopic 2010 novel follows unforgettable characters including a kleptomaniac called Sasha Blake and Bennie Salazar, a punk rocker-turned-ageing record executive who sprinkles gold flakes in his morning coffee in a bid to feel again. It’s often praised for its formal daring: its interlocked narratives shuttle back and forth and one of its best chapters is written as a PowerPoint presentation. But to me, the novel’s ability to evoke time’s quieter tragedies — the ghosts of youth, the slow sapping of desire, the choices that distance us from those we most love – that make it profound. The Italian novelist Elena Ferrante is an elusive figure. The name is a pen-name; Ferrante’s true identity is officially unknown. What we know is that she has published a quartet of evidently autobiographical novels, collectively called the Neapolitan Novels, which prove that fiction in the 21st century can still scale the exhilarating heights that Proust scaled in the 20th. , the disturbing and beautiful first book of Ferrante’s sequence, centres on the narrator’s childhood friendship with the unforgettable Lila. Both girls are ambitious and courageous; both struggle to transcend the limits of the oppressively male world around them. Like Proust, Ferrante has an uncanny memory. She recalls the passions and traumas of her girlhood as if they happened yesterday. The story she tells is in one sense local and particular. But she tells it with a piercing urgency that transforms it into something universal, which has resonated with millions of readers worldwide. Before every book marketed to Millennial women became stamped with a cursory “for fans of Sally Rooney”, there was , the book that kicked off the Irish author’s career and, arguably, an entire literary genre. Despite having released three novels since – each a success in their own right – Conversations is still Rooney at her best. Ultimately, this is a book about relationships: the friendship between college students, poets and former lovers Frances and Bobbi; the marriage between alluring older couple Melissa and Nick; the addictive and, honestly very hot, love affair of Frances and Nick; and the bloodied relationship between Frances and her body. Being a Rooney fan may have become somewhat of a cliche (though one much less painful than that of her literary haters, in my opinion), but there’s no denying this book changed what we considered possible in fiction for, and about, young women. I’m sorry, but Patty Schemel’s memoir of drugs, sex(uality) and existential annihilation is rock and roll. The prose is clean, rigorous and every bit as pacy as Schemel’s drums thrashing and churning during . You don’t necessarily need to care about Seattle grunge, riot grrrl, textured portraits of Kurt Cobain (whose pathos Schemel perfectly evokes here) or exactly what it’s like to throw a puppy-shaped backpack full of Anne Rice paraphernalia at Courtney Love, to appreciate this memoir. Just savour the unexpected, ambient turns of phrase (an addict’s excuses and escape plans, their little bouts of salvation bargaining: the “geographic cure”; Courtney Love playing Melbourne’s Big Day Out with Hole: a “radiant nightmare”.) There is, too, the affecting gallows humour, as in the unexpected punchline to a story of someone casually injecting heroin in their neck during casual conversation; or the eerie moment Schemel, watching the news, sees her own picture displayed during reports of the death of a fellow Hole member. Dumpster-diving, so to speak, through LA dreams and Madonna’s garbage, all while maintaining the kind of stoicism Marcus Aurelius would kill for, Schemel’s voice – graceful, resonant, beguiling – convinced me that, sometimes, the only way out is through. is an exercise in hypnotised reading. Such is the skill of Ottessa Moshfegh, taking us through the story of an appallingly beautiful 26-year old woman who embarks on an ambitious self-imposed quarantine to sleep for a year. The unnamed narrator is a rich, skinny orphaned elite. She approaches her voluntary isolation with the focus of a cyclist about to tackle the Tour de France. It’s mid-June 2000 when her drug-induced hibernation begins. “I didn’t do much in my waking hours besides watch movies,” she announces in the opening pages. Her dogged attempts to detach herself from reality are thwarted (or aided) by a pair of hilarious sidekicks – her psychiatrist, Dr Tuttle, a turtle-neck wearing quack who encourages 14 hours of sleep; and Reva, the painfully jealous loyal friend who suffers from a degree of self-loathing that makes her both utterly detestable and endearing. Saying no to the world that was not made for women, this text therefore feels resolutely feminist. Our heroine’s utter denial of stimuli feels both outrageous and inspiring. No other book captures the sweet malaise that was the late ’90s, pre-9/11 New York era. is a canon-crushing Australian novel for the ages – a grand, whirling hymn of everywhen. Wright’s real-life frustrations at the indignities of the Anthropocene stalk the pages of this bitterly funny book. When a methane-like haze settles over the once-tidy town of , a dreamer – Cause Man Steel – sees an opportunity to capitalise on this new, ferocious era of heat. There’s a fortune to be made, deliverance to be found. Is he a schemer or a visionary? Prophet or fool? His journey will be as absurd as it is epic – a Don Quixote of the dust. “I believe literature must meet the scale of what is happening in the world,” Wright explains. “We have to, even foolishly, believe that anything can be done in life or in literature with deep thought”. is not just the product of deep thought, but an invitation – a mighty and generous invitation – to do the thinking for ourselves. , Robert Hughes (2005) (2009) , Rachel Cusk (2014) , George Saunders (2017) , Richard Powers (2018)Parents, states press Congress to act on kids online safety bill
Teen actor Hudson Meek, who appeared in ‘Baby Driver,’ dies after falling from moving vehicleRIP Manmohan Singh | Tributes pour in for architect of India's economic reformsKylie Kelce ‘slightly offended’ fans think daughter looks like Taylor Swift's boyfriend, Travis Kelce
West Ham goalkeeper Lukasz Fabianski alert and conscious after being taken off on a stretcherNEW YORK , Dec. 10, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Light & Wonder, Inc. (NASDAQ: LNW) resulting from allegations that Light & Wonder may have issued materially misleading business information to the investing public. So What: If you purchased Light & Wonder securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=29678 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. What is this about: On September 24, 2024 , the Las Vegas Review-Journal published an article entitled "Slot manufacturer scores major win against Las Vegas -based rival." The article stated that "Aristocrat Technologies Inc.'s request for a preliminary injunction in its trade-secret and copyright infringement lawsuit against Light & Wonder" had been granted, and that the "order prohibits [Light & Wonder] from the 'continued or planned sale, leasing, or other commercialization of Dragon Train,' which Aristocrat claims uses intellectual property developed for its Dragon Link and Lightning Link games." On this news, Light & Wonder's common stock fell 19.49% on September 24, 2024 . Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-light--wonder-inc-investors-to-inquire-about-securities-class-action-investigation--lnw-302327948.html SOURCE THE ROSEN LAW FIRM, P. A.
Why Miami’s Pop-Tarts Bowl appearance is important even after missing College Football Playoff
AP News Summary at 10:32 a.m. EST
The black and whites reached their fourth consecutive triumph in the great atmosphere of the "Belgrade Arena", which welcomed the current European champions. There were also fans of the visiting team in the stands who caused minor problems before the start, but in the end, it was the host who took the victory on the field. The key part of the game was the end of the first half when Vanja Marinković scored three three-pointers and turned the score in favor of Partizan. After the match, Panathinaikos coach Ergin Ataman had some inappropriate comments, while Željko Obradović expressed his pride in the performance of his players. Frank Nilikina warned his teammates that the fourth victory in a row must not make them overconfident, while Carlik Jones was especially pleased that the entire New Belgrade hall chanted "MVP, MVP". You could follow the match live via our blog. Podeli:Light candles to banish the darkness
The Miami Hurricanes, who once appeared to be a near-lock for the College Football Playoff, are not playing for a national title. Instead, they will play in the Pop-Tarts Bowl in Orlando. That bowl berth against Iowa State is a let-down for fans with dreams of a sixth national title in their minds, as well as players hoping to compete for a championship. However, Miami’s trip to Orlando and the lead-up to it are still crucial periods for the Hurricanes for multiple reasons. First, it’s a chance for the program to achieve something it has not done in more than two decades: win 11 games. Although the 11th win won’t get them closer to a championship, it is a good sign of the program’s progress over Mario Cristobal’s tenure. It would also end UM’s five-game losing streak in bowls. “We’re not satisfied,” Cristobal said. “We want to win every single game. We won 10. We were close on the other two, but close isn’t good enough. We want progress. We’re hungry and driven to get better, and so that’s what our focus is on: to improving as a football program, to getting better, to moving into the postseason with an opportunity against a great football team like this and putting our best on the field.” There are signs the Hurricanes will show up at close to full strength for the bowl game. Running back Damien Martinez announced he was going to play, and star quarterback Cam Ward said in a video call posted on social media that he intends to play, as well. “We’re trying to win our first bowl game in 20 years,” Ward said in the video, mistaking the length of UM’s long bowl losing streak. “We’re going hard.” Playing in the bowl game also provides the opportunity for the Hurricanes to get in several practices between now and the game. That means Miami can develop its young players and prepare them for next season during both the practices and the bowl game itself. “It’s extremely valuable,” Cristobal said. “You really don’t have many opportunities throughout the course of the year — time is limited more and more each season with your student-athletes. I want to state this and be very clear: it’s very important, it’s ultra-important for the University of Miami to continue to develop and grow and progress by stressing the importance of offseason opportunities ... You learn a lot about your team and learn a lot about your people and your program when you head to the postseason.” Of course, there are potential negatives. Players can get hurt; Mark Fletcher Jr. suffered a foot injury in the Pinstripe Bowl last year that cost him all of spring practice. A poor performance can also potentially set the tone for next season, like how Florida State, fresh off a playoff snub last year, suffered a devastating loss against Georgia in the Orange Bowl and went on to a dismal 2-10 season this year. “This is the ending of ’24 and the beginning of ’25,” Cristobal said. “This is the last opportunity to be on the field and carry some momentum into the offseason. So it is, in essence, it is the most important game because it’s the next game. “There’s a lot of excitement in the form of opportunity for our guys. Our guys love to play football. The chance to play one more time with this special group — this is a special group of guys now. They’ve worked hard to really change the trajectory of the University of Miami, and they want to continue to elevate the status and the culture at the University of Miami. So certainly a ton to play for.” ____ Get local news delivered to your inbox!NATO and Ukraine to hold emergency talks after Russian attack with hypersonic missileSlash your bills with a phone call: 7 pro negotiating tips
The judge who presided over Danny Masterson ’s 2023 rape trial and sentencing had a testy exchange with one of the actor’s lawyers in a California courtroom Tuesday, but stopped short of ordering a full-blown evidentiary hearing into claims Masterson’s appellate team acted improperly when it recently tracked down jurors at their homes and workplaces . At a tense hearing in downtown Los Angeles, Judge Charlaine Olmedo ruled that she simply lacked jurisdiction to order such a hearing while Masterson’s conviction is on appeal. Still, she made it clear she was bothered by the way a private investigator approached one specific juror outside her home the afternoon of Sunday, Sept. 15. She called the interaction “tacitly coercive” and said it remains a “mystery” how the appellate team managed to identify approximately six jurors who served during the 2023 trial considering their personal information had been sealed. As she concluded the hearing, the judge said she planned to refer Masterson’s two appellate lawyers to the state bar’s attorney discipline division “for further investigation and action if necessary.” She also said she would contact the state’s Bureau of Security and Investigative Services to report the private investigator’s alleged actions. After the hearing, one of the Jane Does whom Masterson was convicted of raping said the same private investigator has reached out to people connected to her personal life. “I found it objectionable. These are people who had nothing to do with the criminal case. I’m being contacted by these people who are saying they feel harassed,” the Jane Doe forcibly raped by Masterson in 2003 told Rolling Stone . The jurors contacted by the appellate team served on a second trial that ended with Masterson’s conviction in May 2023 . An initial trial on the same charges ended in a mistrial when the prior panel couldn’t reach a unanimous decision. Both trials included emotional testimony from the three women whose allegations led to Masterson’s three charges of forcible rape. All three women said Masterson drugged them before raping them. The women were practicing Scientologists along with Masterson at the time and testified that Church of Scientology officials protected the That ‘70s Show actor. Masterson ultimately was convicted of raping two of the women. Jurors deadlocked on the third alleged victim, voting 8-4 in favor of conviction. Editor’s picks The 100 Best TV Episodes of All Time The 250 Greatest Guitarists of All Time The 500 Greatest Albums of All Time The 200 Greatest Singers of All Time Masterson was sentenced to 30 years to life in September 2023, the same month he filed his appeal. As Masterson pursued both the appeal and a petition challenging his incarceration, his appellate lawyers started looking for jurors willing to discuss possible problems with the trial. Their efforts led multiple jurors to complain to the court. Judge Olmedo sent a letter to prosecutors and Masterson’s defense on Sept. 17, 2024, stating several jurors reported “unwanted contact” where they “may have felt pressured” to talk. She said the jurors were “troubled” they were approached at their homes or workplaces. Los Angeles County Deputy District Attorney Reinhold Mueller, the lead prosecutor on the case, asked the court for an evidentiary hearing. On Tuesday, Mueller said he reviewed the anonymous jury questionnaires from the trial and couldn’t understand how the appellate team identified the jurors beyond the foreperson, who willingly gave some identifying information about her job. Masterson’s trial lawyer Shawn Holley attended the hearing Tuesday and shared with the court some of her personal communications to prove she had only cordial and voluntary post-verdict communications with the foreperson. In a prior declaration, Holley told the court she met with the foreperson for a lunch in Santa Monica shortly after the trial ended. She said the foreperson put her in touch with two more jurors. Judge Olmedo said from the bench Tuesday that she received a follow-up email from the foreperson on Nov. 19, 2024, in which the juror wanted to “clarify” that her contact with Holley was “perfectly appropriate and with her consent.” Related Content Jay-Z Fights Back Against 13-Year-Old Rape Accuser’s Lawsuit, Seeks Dismissal Jay-Z, Sean Combs Accused of Raping 13-Year-Old Girl in Amended Lawsuit Sean Combs Teen Accuser Reveals Name After Judge's Ruling Bassnectar's Motion to Dismiss Sexual Abuse Suit Is Denied, Case Will Head to Trial “The complete blame for harassment is with the appellate attorneys and their private investigator,” the foreperson wrote in the email read aloud by Judge Olmedo. “[The investigator’s] tactics were harassing as she showed up to private residences. We all wondered how she found out where the various jurors lived and worked. And she kept showing up, which is a form of intimidation in our opinion as we continue to communicate via group text.” When the judge turned to Masterson’s habeas lawyer, Eric Multhaup, she pointedly asked how he managed to track down the jurors on his end. Multhaup replied that his investigator is very skilled at her job. The judge seemed skeptical but said her “limited jurisdiction” during the appeals process tied her hands. “How the defense appellate and habeas teams got the names of the trial jurors is a mystery to this court as I have not ordered to unseal [them] and all trial counsel were ordered to not copy them in any way,” she said Tuesday. In one particularly tense exchange, Judge Olmedo pressed Multhaup on what happened with the juror who was approached at her home while doing yard work last September. Olmedo said Multhaup’s investigator failed to follow protocol and first inform the juror that she had a right to stay silent. Multhaup told the court that the juror “interrupted” the investigator before she could give the admonition. He said his investigator “said thank you and walked away.” “No, she didn’t,” Judge Olmedo shot back. “She said, ‘So, you decline to participate?’ In the same breath that she said, ‘So, you decline to participate?’ – which implies there should have been some participation – she should have said, ‘You have an absolute right not to talk to me if you don’t want to.’” Judge Olmedo called the investigator’s response “tacitly coercive” and an apparent violation. “Your honor, you’re putting the cart before the horse,” Multhaup said. “No, I’m not. And I will also indicate that [the juror approached at her home] is a court reporter for the Los Angeles Superior Court. Her job literally is to take down words accurately and be clear on the meaning of those words. So I take great stock in what [she] put down, the order of what took place and the words that were said,” Judge Olmedo shot back. After the hearing ended, a lawyer representing the Jane Does in their civil lawsuit against Masterson and the Church of Scientology asked the judge for a court order maintaining the sealing of everything that was filed under seal during the criminal. He said the worry was that other identifying information might fall into the wrong hands. Judge Olmedo said she wasn’t sure where everything stood amid the appeal but urged the lawyer to file a written application.
SAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024. Fourth quarter 2024 revenue of $1,018.4 million, up 10%, or up 7% organically. Fiscal year 2024 revenue of $3.9 billion, up 8%, or up 8% organically. Fourth quarter 2024 GAAP diluted earnings per share (EPS) of $0.58, up 38%. Fiscal 2024 GAAP diluted EPS of $1.96, up 33%. Fourth quarter 2024 non-GAAP diluted EPS of $1.04, up 19%. Fiscal 2024 non-GAAP diluted EPS of $3.69, up 15%. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "Fiscal 2024 was a great year for Cooper having achieved record consolidated revenues, including record CooperVision revenues, record CooperSurgical revenues and record non-GAAP EPS. We look forward to continued success in fiscal 2025 and thank all of our employees for driving these results." Fourth Quarter Operating Results Revenue of $1,018.4 million, up 10% from last year’s fourth quarter, up 9% in constant currency, up 7% organically. Gross margin of 67% compared with 65% in last year’s fourth quarter driven by price and efficiency gains. On a non-GAAP basis, gross margin was similar to last year at 67%. Operating margin of 19% compared with 15% in last year’s fourth quarter driven by SG&A expense leverage and stronger gross margins. On a non-GAAP basis, operating margin was 26%, up from 24% last year. Interest expense of $27.0 million compared with $26.3 million in last year's fourth quarter. On a non-GAAP basis, interest expense was $25.6 million, down from $26.4 million. Cash provided by operations of $268.1 million offset by capital expenditures of $139.9 million resulted in free cash flow of $128.2 million. Fourth Quarter CooperVision (CVI) Revenue Revenue of $676.4 million, up 9% from last year’s fourth quarter, up 8% in constant currency, up 8% organically. Revenue by category: Revenue by geography: Fourth Quarter CooperSurgical (CSI) Revenue Revenue of $342.0 million, up 12% from last year's fourth quarter, up 12% in constant currency, up 5% organically. Revenue by category: Fiscal Year 2024 Operating Results Revenue of $3,895.4 million, up 8% from fiscal 2023, up 9% in constant currency, up 8% organically. CVI revenue of $2,609.4 million, up 8% from fiscal 2023, up 8% in constant currency, up 9% organically, and CSI revenue $1,286.0 million, up 10% from fiscal 2023, up 11% in constant currency, up 5% organically. Gross margin of 67% compared with 66% in fiscal 2023. Non-GAAP gross margin was 67% compared with 66% in fiscal 2023. Operating margin of 18% compared with 15% in fiscal 2023. Non-GAAP operating margin was 25% compared with 24% in fiscal 2023. Cash provided by operations of $709.3 million offset by capital expenditures of $421.2 million resulted in free cash flow of $288.1 million. Fiscal Year 2025 Financial Guidance The Company initiated its fiscal year 2025 financial guidance. Details are summarized as follows: Fiscal 2025 total revenue of $4,080 - $4,158 million (organic growth of 6% to 8%) CVI revenue of $2,733 - $2,786 million (organic growth of 6.5% to 8.5%) CSI revenue of $1,347 - $1,372 million (organic growth of 4% to 6%) Fiscal 2025 non-GAAP diluted earnings per share of $3.92 - $4.02 Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and certain income or gains and charges or expenses including acquisition and integration costs which we may incur as part of our continuing operations. With respect to the Company’s guidance expectations, the Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses, which are reconciling items between the non-GAAP and GAAP measures. Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, the Company is not able to provide such guidance. Reconciliation of Selected GAAP Results to Non-GAAP Results To supplement our financial results and guidance presented on a GAAP basis, we provide non-GAAP measures such as non-GAAP gross margin, non-GAAP operating margin, non-GAAP diluted earnings per share, as well as constant currency and organic revenue growth because we believe they are helpful for the investors to understand our consolidated operating results. Management uses supplemental non-GAAP financial measures internally to understand, manage and evaluate our business, to make operating decisions, and to plan and forecast for future periods. The non-GAAP measures exclude costs which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. We provide further details of the non-GAAP adjustments made to arrive at our non-GAAP measures in the GAAP to non-GAAP reconciliations below. Our non-GAAP financial results and guidance are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. To present constant currency revenue growth, current period revenue for entities reporting in currencies other than the United States dollar are converted into United States dollars at the average foreign exchange rates for the corresponding period in the prior year. To present organic revenue growth, we excluded the effect of foreign currency fluctuations and the impact of any acquisitions, divestitures and discontinuations that occurred in the comparable period. We define the non-GAAP measure of free cash flow as cash provided by operating activities less capital expenditures. We believe free cash flow is useful for investors as an additional measure of liquidity because it represents cash that is available to grow the business, make strategic acquisitions, repay debt, or buyback common stock. Management uses free cash flow internally to understand, manage, make operating decisions and evaluate our business. In addition, we use free cash flow to help plan and forecast future periods. Investors should consider non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP. EPS, amounts and percentages may not sum or recalculate due to rounding. (1) Charges include the direct effects of acquisition accounting, such as amortization of inventory fair value step-up, professional services fees, regulatory fees and changes in fair value of contingent considerations, and items related to integrating acquired businesses, such as redundant personnel costs for transitional employees, other acquired employee related costs, and integration-related professional services, manufacturing integration costs, legal entity rationalization and other integration-related activities. The acquisition and integration-related charges in fiscal 2024 were primarily related to the Cook Medical acquisition and integration expenses. The acquisition and integration-related charges in fiscal 2023 were primarily related to the Generate acquisition and integration expenses. Charges included $2.9 million and $8.4 million related to redundant personnel costs for transitional employees, $0.7 million and $4.5 million of professional services fees, $1.4 million and $1.4 million of manufacturing integration costs, $1.5 million and 1.5 million of inventory fair value step-up amortization, and $0.7 million and $4.1 million of other acquisition and integration-related activities in the three and twelve months ended October 31, 2024, respectively. The twelve months ended October 31, 2024 also included $0.7 million regulatory fees. Charges included $7.5 million and $21.9 million related to redundant personnel costs for transitional employees, $6.5 million and $16.2 million of professional services fees, $2.9 million and $6.5 million of manufacturing integration costs, $3.1 million and $5.0 million of legal entity rationalization costs, $0.9 million and $2.7 million regulatory fees, and $0.6 million and $5.0 million in other acquisition and integration-related activities, in the three and twelve months ended October 31, 2023, respectively. (2) Charges include costs related to product line exits such as inventory write-offs, site closure costs, contract termination costs and specifically-identified long-lived asset write-offs. Charges included $2.3 million of write-offs of long-lived assets and $1.7 million of other costs related to product line exits in the twelve months October 31, 2024. No charge related to product line exits was incurred in the three months ended October 31, 2024. Charges included $3.4 million and $7.9 million of site closure costs related to the exit of the lens care business, $0.4 million and $1.1 million of other costs related to product line exits in the three and twelve months ended October 31, 2023, respectively. The fourth quarter of fiscal 2023 also included $9.8 million of intangible assets impairment charge associated with the discontinuation of certain products. (3) Charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be limited to a specific time period. (4) Charges represent the costs associated with initiatives to increase efficiencies across the organization and optimize our overall cost structure, including changes to our IT infrastructure and operations, employee severance costs, legal entity and other business reorganizations, write-offs or impairments of certain long-lived assets associated with the business optimization activities. Charges included $1.5 million and $10.6 million of employee severance costs, $1.0 million and $4.1 million related to changes to our IT infrastructure and operation, and $0.4 million and $2.9 million of legal entity and other business reorganizations costs, in the three and twelve months ended October 31, 2024, respectively. The twelve months ended October 31, 2024 also included $0.7 million of other optimization costs. Charges included $1.4 million and $11.3 million of employee severance costs, $1.4 million and $1.9 million of legal entity and other business reorganizations costs, and $0.3 million and $5.9 million related to changes to our IT infrastructure and operations, partially offset by $0.2 million and $0.4 million of other items in the three and twelve months ended October 31, 2023, respectively. (5) Amount represents an accrual for probable payment of a termination fee in connection with an asset purchase agreement in the second quarter of 2023, which was paid in August 2023. (6) Amount represents the release the contingent consideration liability associated with SightGlass Vision's regulatory approval milestone in the first quarter of 2023. (7) Charges include certain business disruptions from natural causes, litigation matters and other items that are not part of ordinary operations. The adjustments to arrive at non-GAAP net income also include gains and losses on minority interest investments and accretion of interest attributable to acquisition installment payables. Charges included $1.5 million and $5.9 million of gains and losses on minority interest investments, $1.4 million and $5.5 million of accretion of interest attributable to acquisition installments payable, $0.6 million and $1.5 million related to legal matters in the three and twelve months ended October 31, 2024, respectively. Charges included $1.6 million and $6.3 million of gains and losses on minority interest investments, and $1.3 million and $4.6 million related to legal matters in the three and twelve months ended October 31, 2023, respectively. The twelve months ended October 31, 2023 also included $1.1 million of other items. (8) In fiscal 2021, the Company transferred its CooperVision intellectual property and goodwill to its UK subsidiary. As a result, we recorded a deferred tax asset equal to approximately $2.0 billion as a one-time tax benefit in accordance with U.S. GAAP in fiscal 2021 as subsequently adjusted for changes in UK tax law. The non-GAAP adjustments reflect the ongoing net deferred tax benefit from tax amortization each period under UK tax law. Audio Webcast and Conference Call The Company will host an audio webcast today for the public, investors, analysts and news media to discuss its fourth quarter results and current corporate developments. The audio webcast will be broadcast live on CooperCompanies' website, www.investor.coopercos.com , at approximately 5:00 PM ET. It will also be available for replay on CooperCompanies' website, www.investor.coopercos.com . Alternatively, you can dial in to the conference call at 800-715-9871; conference ID 2026064. About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women's health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies ("Cooper") has a workforce of more than 16,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com. Forward-Looking Statements This earnings release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements of which are other than statements of historical fact, including our fiscal year 2025 financial guidance are forward looking. In addition, all statements regarding anticipated growth in our revenues, anticipated effects of any product recalls, anticipated market conditions, planned product launches, restructuring or business transition expectations, regulatory plans, and expected results of operations and integration of any acquisition are forward-looking. To identify these statements look for words like "believes," "outlook," "probable," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: adverse changes in the global or regional general business, political and economic conditions including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items; the impact of international conflicts and the global response to international conflicts on the global and local economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, affected countries; our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of legal, compliance and regulatory requirements; foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings; our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds; changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income; acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms); compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the California Consumer Privacy Act (CCPA) in the U.S. and the General Data Protection Regulation (GDPR) requirements in Europe, including but not limited to those resulting from data security breaches; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to challenges associated with integration of acquisitions, man-made or natural disasters, pandemic conditions, cybersecurity incidents or other causes; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to the failure to perform by third-party vendors, including cloud computing providers or other technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades; a successful cybersecurity attack which could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data; market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers; disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR), and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR); legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement, contractual disputes, or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions; reduced sales, loss of customers, reputational harm and costs and expenses, including from claims and litigation related to product recalls and warning letters; failure to receive, or delays in receiving, regulatory approvals or certifications for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payers for our products and services; the requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment; the success of our research and development activities and other start-up projects; dilution to earnings per share from acquisitions or issuing stock; impact and costs incurred from changes in accounting standards and policies; risks related to environmental laws and requirements applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products; risks related to environmental, social and corporate governance (ESG) issues, including those related to regulatory and disclosure requirements, climate change and sustainability; and other events described in our Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, as such Risk Factors may be updated in annual and quarterly filings. We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law. Contact: Kim Duncan Vice President, Investor Relations and Risk Management 925-460-3663 ir@cooperco.com THE COOPER COMPANIES, INC. AND SUBSIDIARIES GAAP to Non-GAAP Reconciliation Constant Currency Revenue Growth and Organic Revenue Growth Net SalesFRISCO, Texas (AP) — Dallas Cowboys linebacker DeMarvion Overshown could miss the 2025 season recovering from the right knee injury sustained in a loss to Cincinnati, coach Mike McCarthy said Tuesday. McCarthy said Overshown has a “long road of rehab in front of him.” The second-year player tore multiple ligaments when a Bengals lineman crashed into his leg in the Cowboys' 27-20 loss Monday night. Overshown missed all of his rookie year in 2023 after tearing the ACL in his left knee in a preseason game. The latest injury came in his first game since a spectacular 23-yard interception return for a touchdown in a 27-20 victory over the New York Giants on Thanksgiving. “DeMarvion is getting ready to have a big surgery in front of him,” McCarthy said of the procedure planned this week. “His physical and football talent speaks for itself. He’s such a bright light. He’s got a great, infectious personality — a tough young man. He is definitely going to be missed.” The former Texas standout, drafted in the third round last year, was second on the team to star pass rusher Micah Parsons with five sacks when he went down. The December timing of Overshown's injury means rehab is likely to extend past training camp and into the regular season next year, after he turns 25. Parsons was emotional when asked about Overshown after the Cincinnati game. “I cried,” he said. “It’s like my little bro, bro. He doesn’t deserve that either. Just to understand what he’s going to go through and to be there for him physically, mentally. It’s just so challenging because of the year he was having. I really just don’t think that’s fair either.” The loss of Overshown comes with defensive end DeMarcus Lawrence close to return from a foot injury that has sidelined him since Week 4. But the Cowboys (5-8) are all but out of the playoffs as they prepare to visit Carolina (3-10) on Sunday. AP NFL: https://apnews.com/hub/nfl
NoneWASHINGTON (AP) — President-elect Donald Trump has promised to as soon as he gets into office to make good on campaign promises aiming and redefining what it means to be American. But any efforts to halt the policy would face steep legal hurdles. Birthright citizenship means anyone born in the United States automatically becomes an American citizen. It’s been in place for decades and applies to children born to someone in the country illegally or in the U.S. on a tourist or student visa who plans to return to their home country. It’s not the practice of every country, and Trump and his supporters have argued that the system is being abused and that there should be tougher standards for becoming an American citizen. But others say this is a right enshrined in the 14th Amendment to the Constitution, it would be extremely difficult to overturn and even if it’s possible, it’s a bad idea. Here’s a look at birthright citizenship, what Trump has said about it and the prospects for ending it: During an interview Sunday on Trump said he “absolutely” planned to halt birthright citizenship once in office. “We’re going to end that because it’s ridiculous,” he said. Trump and other opponents of birthright citizenship have argued that it creates an incentive for people to come to the U.S. illegally or take part in pregnant women enter the U.S. specifically to give birth so their children can have citizenship before returning to their home countries. “Simply crossing the border and having a child should not entitle anyone to citizenship,” said Eric Ruark, director of research for NumbersUSA, which argues for reducing immigration. The organization supports changes that would require at least one parent to be a permanent legal resident or a U.S. citizen for their children to automatically get citizenship. Others have argued that ending birthright citizenship would profoundly damage the country. “One of our big benefits is that people born here are citizens, are not an illegal underclass. There’s better assimilation and integration of immigrants and their children because of birthright citizenship,” said Alex Nowrasteh, vice president for economic and social policy studies at the pro-immigration Cato Institute. In 2019, the Migration Policy Institute estimated that 5.5 million children under age 18 lived with at least one parent in the country illegally in 2019, representing 7% of the U.S. child population. The vast majority of those children were U.S. citizens. The nonpartisan think tank said during Trump’s campaign for president in 2015 that the number of people in the country illegally would “balloon” if birthright citizenship were repealed, creating “a self-perpetuating class that would be excluded from social membership for generations.” In the aftermath of the Civil War, Congress ratified the 14th Amendment in July 1868. That amendment assured citizenship for all, including Black people. “All persons born or naturalized in the United States and subject to the jurisdiction thereof, are citizens of the United States and of the State wherein they reside,” the 14th Amendment says. “No State shall make or enforce any law which shall abridge the privileges or immunities of citizens of the United States.” But the 14th Amendment didn’t always translate to everyone being afforded birthright citizenship. For example, it wasn’t until 1924 that Congress finally granted citizenship to all Native Americans born in the U.S. A key case in the history of birthright citizenship came in 1898, when the U.S. Supreme Court ruled that Wong Kim Ark, born in San Francisco to Chinese immigrants, was a U.S. citizen because he was born in the states. The federal government had tried to deny him reentry into the county after a trip abroad on grounds he wasn’t a citizen under the Chinese Exclusion Act. But some have argued that the 1898 case clearly applied to children born of parents who are both legal immigrants to America but that it’s less clear whether it applies to children born to parents without legal status or, for example, who come for a short-term like a tourist visa. “That is the leading case on this. In fact, it’s the only case on this,” said Andrew Arthur, a fellow at the Center for Immigration Studies, which supports immigration restrictions. “It’s a lot more of an open legal question than most people think.” Some proponents of immigration restrictions have argued the words “subject to the jurisdiction thereof” in the 14th Amendment allows the U.S. to deny citizenship to babies born to those in the country illegally. Trump himself used that language in his 2023 announcement that he would aim to end birthright citizenship if reelected. Trump wasn’t clear in his Sunday interview how he aims to end birthright citizenship. Asked how he could get around the 14th Amendment with an executive action, Trump said: “Well, we’re going to have to get it changed. We’ll maybe have to go back to the people. But we have to end it.” Pressed further on whether he’d use an executive order, Trump said “if we can, through executive action.” He gave a lot more details in a . In it, he said he would issue an executive order the first day of his presidency, making it clear that federal agencies “require that at least one parent be a U.S. citizen or lawful permanent resident for their future children to become automatic U.S. citizens.” Related Articles Trump wrote that the executive order would make clear that children of people in the U.S. illegally “should not be issued passports, Social Security numbers, or be eligible for certain taxpayer funded welfare benefits.” This would almost certainly end up in litigation. Nowrasteh from the Cato Institute said the law is clear that birthright citizenship can’t be ended by executive order but that Trump may be inclined to take a shot anyway through the courts. “I don’t take his statements very seriously. He has been saying things like this for almost a decade,” Nowrasteh said. “He didn’t do anything to further this agenda when he was president before. The law and judges are near uniformly opposed to his legal theory that the children of illegal immigrants born in the United States are not citizens.” Trump could steer Congress to pass a law to end birthright citizenship but would still face a legal challenge that it violates the Constitution.
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |